In a study including 36 COVID-19 patients, roughly 22% of the individuals developed thrombotic events, but curiously platelet activation biomarkers (P-selectin, soluble P-selectin, platelet-derived microparticles), though elevated, did not correlate with disease severity and thrombosis (151). This evidence concerns the gene SELP and COVID-19.